AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 2.00 BATS BZX Real-Time Price As of 12:19pm ET |  +0.01 / +0.50%Today’s Change | 1.76 Today|||52-Week Range 10.18 | -11.50% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 107.9M | 80.3M | 52.9M | 88.0M | |
| Short Term Investment Cash | 47.9M | -27.6M | -27.4M | 35.1M | ||
| Cash & Short Term Investments | 113.5M | 80.3M | 60.5M | 105.7M | ||
| Receivables | Receivables | 3.3M | 5.8M | 1.5M | 401.0K | |
| Inventories | Inventories | 466.0K | 2.2M | 956.0K | 854.0K | |
| Current Assets | Other Current Assets | 1.7M | 756.0K | 455.0K | 1.0M | |
| Current Assets | 118.9M | 89.1M | 63.4M | 108.0M | ||
| Total Assets | Property, Plant and Equipment - Gross | 13.5M | 17.4M | 19.5M | 20.4M | |
| Depreciation | -4.9M | -6.7M | -8.4M | -8.9M | ||
| Other Assets | 50.0K | 50.0K | 207.0K | 527.0K | ||
| Total Assets | 127.8M | 100.0M | 75.6M | 120.5M | ||
| Liabilities | Accounts Payable | 1.6M | 1.6M | 1.4M | 2.1M | |
| Short Term Debt | 4.7M | 3.7M | 8.3M | 9.0M | ||
| Accrued Expenses | 1.1M | 2.0M | 1.4M | 929.0K | ||
| Other Current Liabilities | 3.7M | 2.4M | 1.7M | 1.2M | ||
| Other Liabilities | 12.8M | 10.2M | 13.7M | 15.9M | ||
| Total Liabilities | Long Term Debt | 80.1M | 90.9M | 94.4M | 96.7M | |
| Other Liabilities | 913.0K | 455.0K | 585.0K | 537.0K | ||
| Total Liabilities | 94.7M | 105.3M | 112.1M | 116.3M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 33.1M | -5.3M | -36.5M | 4.3M | ||
| Total Shareholder Equity | 33.1M | -5.3M | -36.5M | 4.3M | ||
| Share Information | Common Shares Outstanding | 45.3M | 45.3M | 50.9M | 78.8M | |
| Addtl. Info. | No data currently available for this section. | |||||
